Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 7, 2013 · 10-Q · 38 days after period end · 0001193125-13-432841
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$10.05M | -$5.92M | $4.47M | -$6.89M |
| EPS Diluted | -$0.68 | $0.40 | $0.45 | $1.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 7, 2013 · 38 d after period end
